BMS-986142

N/A

Report date: 2023/05/03 20:00:19
NME

Base Information

Drug NameBMS-986142
Drug Alias NameBMS-986142
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsSjogren-Larsson SyndromeArthritis, RheumatoidArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[22
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSjogren-Larsson SyndromeArthritis, RheumatoidArthritis

Other Information

ATC CodeN/A
Related LinksN/A